Cargando…
Pathogenesis of Respiratory Syncytial Virus Infection in BALB/c Mice Differs Between Intratracheal and Intranasal Inoculation
Human respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract disease requiring hospitalization in infants. There are no market-approved vaccines or antiviral agents available, but a growing number of vaccines and therapeutics are in (pre)clinical stages of development....
Autores principales: | van Erp, Elisabeth A., Lakerveld, Anke J., Mulder, H. Lie, Luytjes, Willem, Ferwerda, Gerben, van Kasteren, Puck B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631102/ https://www.ncbi.nlm.nih.gov/pubmed/31163619 http://dx.doi.org/10.3390/v11060508 |
Ejemplares similares
-
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
por: van Erp, Elisabeth A., et al.
Publicado: (2019) -
Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function
por: van Erp, Elisabeth A, et al.
Publicado: (2019) -
Binding of respiratory syncytial virus particles to platelets does not result in their degranulation in vitro
por: Lakerveld, Anke J., et al.
Publicado: (2023) -
In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants
por: van Erp, Elisabeth A., et al.
Publicado: (2017) -
Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation
por: van Erp, Elisabeth A, et al.
Publicado: (2020)